Abstract 1754: First in class orally bioavailable BETBRD degraders
Abbineni, Chandrasekhar, Jaleel, Mahaboobi, Mukherjee, Subhendu, Marappan, Sivapriya, Tiwari, Nirbhay Kumar, Samiulla, DS, Aravind, AB, Kumar, Naveen R, Bansal, Indu, Reddy, Raghurami B, Bandaru, NVM Rao, Srinivas, Akhila, Maben, Janith Mary, Tgore, Suraj, Kumar, Avainash, Nankar, Rakesh P., Naik, Chandranath D., Antony, Thomas, Nellore, Kavitha, Giri, Sanjeev, Daginakatte, Girish, Chelur, Shekar, Törmäkangas, Olli, Wohlfahrt, Gerd, Björkman, Mari, Mattila, Elina, Ravanti, Laura, Moilanen, Anu, Ramachandra, Murali, Samajdar, Susanta
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Abstract C127: Discovery of AUR-112, a novel MALT1 protease inhibitor for the treatement of B cell lymphomas
Balasubramanian, Wesley Roy, Raju, Sammeta Srinivasa, K.Y, Vasantha, Reddy, Archana Bhumi, Maben, Janith Mary, Patil, Sandeep Sadashiv, N.R, Raghavendra, B, Kiran Aithal, K.B, Charamanna, Chikkanna, Dinesh, Nellore, Kavitha, D.S, Samiulla, Daginakatte, Girish, Chelur, Shekar, Ramachandra, Murali, Samajdar, Susanta
Published in Molecular cancer therapeutics (01.12.2023)
Published in Molecular cancer therapeutics (01.12.2023)
Get full text
Journal Article